Published in Antimicrob Agents Chemother on May 01, 1985
SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother (1989) 2.60
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicrob Agents Chemother (1992) 1.71
In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics. Antimicrob Agents Chemother (1987) 1.21
Improved sensitivity in assays for binding of novel beta-lactam antibiotics to penicillin-binding proteins of Escherichia coli. Antimicrob Agents Chemother (1987) 1.08
Pharmacokinetics of carumonam in patients with renal insufficiency. Antimicrob Agents Chemother (1986) 1.01
In vitro activity of carumonam. Antimicrob Agents Chemother (1985) 0.98
Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5. J Clin Microbiol (1987) 0.93
Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs. Antimicrob Agents Chemother (1986) 0.87
Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother (1986) 0.86
In vitro activity and beta-lactamase stability of a new monobactam, B0-1165. Antimicrob Agents Chemother (1987) 0.84
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods. J Clin Microbiol (1987) 0.82
In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608. Antimicrob Agents Chemother (1990) 0.82
Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens. Antimicrob Agents Chemother (1988) 0.80
In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila. Antimicrob Agents Chemother (1988) 0.79
Mechanism of renal excretion of carumonam in rats, rabbits, dogs, and monkeys. Antimicrob Agents Chemother (1987) 0.75
Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis. Antimicrob Agents Chemother (1991) 0.75
Preferential hydrolysis of cis configuration compounds at the 3,4 position of monobactams by beta-lactamase from Morganella morganii. Antimicrob Agents Chemother (1991) 0.75
Carumonam versus ceftazidime for urinary tract infections. Antimicrob Agents Chemother (1988) 0.75
The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol (1973) 25.78
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob Agents Chemother (1982) 9.58
Plasmid-mediated beta-lactamases of Gram-negative bacteria: properties and distribution. J Antimicrob Chemother (1979) 7.39
GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother (1980) 6.77
SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1978) 5.24
In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin. Antimicrob Agents Chemother (1979) 4.49
Sulfazecin and isosulfazecin, novel beta-lactam antibiotics of bacterial origin. Nature (1981) 2.84
Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin. Antimicrob Agents Chemother (1981) 2.72
Mode of action of azthreonam. Antimicrob Agents Chemother (1982) 1.86
SCE-963, a new potent cephalosporin with high affinity for penicillin-binding proteins 1 and 3 of Escherichia coli. Antimicrob Agents Chemother (1979) 1.56
Activity of beta-lactam antibiotics against Pseudomonas aeruginosa carrying R plasmids determining different beta-lactamases. Antimicrob Agents Chemother (1979) 1.34
Evaluation of the Titertek Multiskan for determining minimal inhibitory concentration endpoints. Antimicrob Agents Chemother (1982) 1.21
Synthesis of sulfazecin-type 2-azetidinones with a carbon substituent at the 4-position. J Antibiot (Tokyo) (1983) 1.00
Nrl is required for rod photoreceptor development. Nat Genet (2001) 5.68
SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1978) 5.24
Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res (1995) 4.52
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A (1999) 4.46
Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett (1992) 4.31
Correlation between nerve terminal size and transmitter release at the neuromuscular junction of the frog. J Physiol (1971) 4.25
Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell (1997) 4.18
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst (2001) 4.14
SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1978) 4.06
Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature (1987) 3.50
cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature (1987) 3.31
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother (1991) 3.05
Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1981) 3.03
Expression of functional sodium channels from cloned cDNA. Nature (1986) 2.95
Sulfazecin and isosulfazecin, novel beta-lactam antibiotics of bacterial origin. Nature (1981) 2.84
2,4-Dichlorophenoxybutyric acid-resistant mutants of Arabidopsis have defects in glyoxysomal fatty acid beta-oxidation. Plant Cell (1998) 2.79
Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin. Antimicrob Agents Chemother (1981) 2.72
The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol (1996) 2.50
Expression of functional acetylcholine receptor from cloned cDNAs. Nature (1984) 2.41
Subunit structure of Q-beta replicase. Nature (1970) 2.30
P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci (2000) 2.23
Non-linear summation of unit synaptic potentials in spinal motoneurones of the cat. J Physiol (1969) 2.20
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res (1999) 2.20
Enhancement of synaptic transmission by dendritic potentials in chromatolysed motoneurones of the cat. J Physiol (1970) 2.19
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution. Genetics (2000) 2.19
Chemical and electron microscope studies on fractions prepared from coats of Bacillus spores. J Gen Microbiol (1967) 2.14
Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol (1999) 2.11
Quantum aspects of central and ganglionic synaptic transmission in vertebrates. Physiol Rev (1971) 2.07
Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice. Infect Immun (1983) 2.06
Differential reaction of fast and slow alpha-motoneurones to axotomy. J Physiol (1974) 2.03
Effect of a thromboxane A(2) antagonist on sputum production and its physicochemical properties in patients with mild to moderate asthma. Chest (2000) 1.98
Asparaginase and glutaminase activities of micro-organisms. J Gen Microbiol (1973) 1.97
Reconstitution of Q replicase lacking subunit with protein-synthesis-interference factor i. Eur J Biochem (1972) 1.88
Single-channel and whole-cell recordings of mitogen-regulated inward currents in human cloned helper T lymphocytes. Nature (1986) 1.78
Emergence of methicillin-resistant clones from cephamycin-resistant Staphylococcus aureus. J Antimicrob Chemother (1989) 1.76
The medaka rs-3 locus required for scale development encodes ectodysplasin-A receptor. Curr Biol (2001) 1.75
Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut (1993) 1.75
A subtilisin-like serine protease is required for epidermal surface formation in Arabidopsis embryos and juvenile plants. Development (2001) 1.73
Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int (1991) 1.73
Alterations of synaptic action in chromatolysed motoneurones of the cat. J Physiol (1970) 1.72
Comparative in vitro activities of SCE-129, sulbenicillin, gentamicin, and dibekacin against Pseudomonas. Antimicrob Agents Chemother (1978) 1.72
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicrob Agents Chemother (1992) 1.71
Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci U S A (2001) 1.67
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci U S A (2001) 1.67
15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest (2000) 1.64
Vacuolar processing enzyme is up-regulated in the lytic vacuoles of vegetative tissues during senescence and under various stressed conditions. Plant J (1999) 1.63
Analysis of synaptic efficacy in spinal motoneurones from 'quantum' aspects. J Physiol (1969) 1.63
On the fundamental nature and evolution of the genetic code. Cold Spring Harb Symp Quant Biol (1966) 1.62
The AtVAM3 encodes a syntaxin-related molecule implicated in the vacuolar assembly in Arabidopsis thaliana. J Biol Chem (1997) 1.60
Two photocycles in halobacterium halobium that lacks bacteriorhodopsin. Biochem Biophys Res Commun (1982) 1.59
Solid-liquid phase boundaries of lens protein solutions. Proc Natl Acad Sci U S A (1992) 1.59
Analysis of spontaneous subthreshold activity in spinal motoneurons of the cat. J Neurophysiol (1968) 1.57
Properties of fast and slow alpha motoneurones following motor reinnervation. J Physiol (1974) 1.57
Quantal components of the inhibitory synaptic potential in spinal mononeurones of the cat. J Physiol (1972) 1.56
SCE-963, a new potent cephalosporin with high affinity for penicillin-binding proteins 1 and 3 of Escherichia coli. Antimicrob Agents Chemother (1979) 1.56
Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res (1998) 1.55
Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci (2001) 1.55
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) (2006) 1.53
Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun (2000) 1.52
Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group. Lancet (2000) 1.51
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Eur J Endocrinol (1997) 1.50
Evidence for the maintenance of motoneurone properties by muscle activity. J Physiol (1978) 1.50
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther (2000) 1.48
Occult macular dystrophy. Am J Ophthalmol (1996) 1.46
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer (2005) 1.45
Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido-3. J Antibiot (Tokyo) (2001) 1.43
Membrane properties and conduction velocity in sensory neurones following central or peripheral axotomy. J Physiol (1977) 1.43
Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med (1998) 1.41
Factors responsible for multiple discharge of neurons in Clarke's column. J Neurophysiol (1968) 1.40
Differential effects of carbon dioxide and pH on central chemoreceptors in the rat in vitro. J Physiol (1985) 1.39
Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int Immunol (1995) 1.39
Multifocal electroretinogram in occult macular dystrophy. Invest Ophthalmol Vis Sci (2000) 1.38
Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res (1997) 1.38
Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus. Intern Med (1997) 1.38
The common gamma-chain for multiple cytokine receptors. Adv Immunol (1995) 1.38
Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium. Rheumatology (Oxford) (2000) 1.36
AtPex14p maintains peroxisomal functions by determining protein targeting to three kinds of plant peroxisomes. EMBO J (2000) 1.35
Calcium dependence of membrane sealing at the cut end of the cockroach giant axon. J Neurosci (1985) 1.34
Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res (1991) 1.33
Retinal remodeling. Jpn J Ophthalmol (2012) 1.32
Complete nucleotide sequence of the E. coli glutathione synthetase gsh-II. Nucleic Acids Res (1984) 1.32
Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res (2000) 1.31
The release of acetylcholine from the spinal cord of the cat by antidromic stimulation of motor nerves. J Physiol (1966) 1.31
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Clin Cancer Res (1999) 1.29
Targeting and processing of a chimeric protein with the N-terminal presequence of the precursor to glyoxysomal citrate synthase. Plant Cell (1996) 1.29
An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine (2000) 1.29
Triggering of T-lymphocytes via either T3-Ti or T11 surface structures opens a voltage-insensitive plasma membrane calcium-permeable channel: requirement for interleukin-2 gene function. J Biol Chem (1989) 1.28
Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. I: Synthesis and biological properties of pyrrolo[2,3-d]pyrimidine antifolates containing tetrazole congener of glutamic acid. Chem Pharm Bull (Tokyo) (1995) 1.28
Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in yellow KK mice. Life Sci (1994) 1.27
Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med (1995) 1.27
Ribosyl and deoxyribosyl transfer by bacterial enzyme systems. J Bacteriol (1967) 1.25
A novel acyl-CoA oxidase that can oxidize short-chain acyl-CoA in plant peroxisomes. J Biol Chem (1999) 1.25
Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene (1998) 1.24
Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung (1993) 1.23